ESHG 2026 Corporate Satellite
Advancing Diagnostics: From Clinical Implementation to Biomarker Discovery
Room A3 | Saturday, 13 June | 12:15 - 13:30
About The Satellite Session
This corporate satellite brings together clinical, translational, and research perspectives to explore how genomics is advancing oncology - from real-world implementation to next-generation biomarker discovery.
Hear directly from leading institutes and partners working at the forefront of clinical diagnostics, comparative genomics, and multi-omics innovation.
Hear directly from leading institutes and partners working at the forefront of clinical diagnostics, comparative genomics, and multi-omics innovation.
Venue
Room A3
Date & Time
Saturday 13 June
12:15 - 13:30
12:15 - 13:30
Lunch
Lunch Provided
Meet our corporate satellite speakers who are at the forefront of genomics innovation
Dr. Raquel T. Lima
Researcher @ IPATIMUP (Portugal)
The added value of RNA-seq for detecting actionable fusions in solid tumors
Dr. Andrea Conti
Bioinformatician @ BMR Genomics (Italy)
Pharmacogenetic markers evaluation opportunities via whole genome sequencing
Prof. Dr. Andreas Braun
Professor for Digital and Molecular Dermatopathology, Head of Division @ University of Lübeck (Germany)
Mapping Melanoma: How Spatial Biology Is Advancing Cancer Research & precision oncology
Visit MGI at Booth #352
Powering Large-Scale Genomics with T7+
T7+
Powered by DNBSEQ™ technology and SM2.0 chemistry, the T7+ enables rapid, cost-efficient sequencing at scale - supporting demanding genomics applications from research to clinical workflows.
Designed for population genomics and high-throughput sequencing, the T7+ delivers the scale, speed, and accuracy needed for next-generation research.
• Up to 14 Tb per run
• >40B reads per run
• Q40+ accuracy
• Fully automated modular workflow
Ultra-High Throughput Sequencing
Featured Talks and Posters at ESHG 2026
Join our researchers in the official ESHG scientific program and discover the latest innovations in genomics, multi-omics, and clinical diagnostics.
- Dr. Heng YiPanVariants: best practice for pangenome-based variant calling pipeline and fameworkE-poster
- Dr. Zhouchun ShangSpatiotemporal multi-omics uncovers an “infection-tumor immunocompetition” landscape in co-existing tuberculosis and lung cancerE-poster